MAPT and Alzheimer disease: Among the AI-selected molecules, two bioavailable compounds, e.g., Kaempferol and Rhapontigenin, seem to stimulate mitophagy and, hence, mitochondria degradation, leading to increased survival and functionality glutamatergic and cholinergic neurons, abrogating amyloid-β and tau pathologies, and improving cognitive functions in nematode and rodent models of Alzheimer’s disease (AD) [58].